[1]Patent:CN106831821,2017,A,.Locationinpatent:Paragraph0025;0026;0029;0030;0033;0034;0037-0039
[1]TetrahedronLetters,2000,vol.41,#20,p.3899-3901
[1]AdvancedSynthesisandCatalysis,2003,vol.345,#6-7,p.783-789
[2]JournalofMolecularCatalysisB:Enzymatic,2012,vol.76,p.52-58
[1]TetrahedronLetters,2000,vol.41,#20,p.3899-3901
[1]Patent:WO2012/32040,2012,A1,.Locationinpatent:Page/Pagecolumn10-11
[2]JournalofMolecularCatalysisB:Enzymatic,2012,vol.76,p.52-58
[1]PharmaceuticalChemistryJournal,1992,vol.26,p.169-173 Khimiko-FarmatsevticheskiiZhurnal,1992,vol.26,p.54-56
[1]PharmaceuticalChemistryJournal,1992,vol.26,p.169-173 Khimiko-FarmatsevticheskiiZhurnal,1992,vol.26,p.54-56
[1]IlFarmaco,1994,vol.49,p.201-204
[1]ChemistryofHeterocyclicCompounds,1984,vol.20,p.256-261 KhimiyaGeterotsiklicheskikhSoedinenii,1984,vol.20,p.321-326
[1]ArchivderPharmazie,1994,vol.327,p.805-807
Title: Linda G Otten, et al. Mutational Analysis of a Key Residue in the Substrate Specificity of a Cephalosporin Acylase. Chembiochem. 2004 Jun 7;5(6):820-5.